The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis

Marco Genua, Sergio Rutella, Carmen Correale, Silvio Danese

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

The Triggering Receptors Expressed on Myeloid cells (TREM) are a family of cell-surface molecules that control inflammation, bone homeostasis, neurological development and blood coagulation. TREM-1 and TREM-2, the best-characterized receptors so far, play divergent roles in several infectious diseases. In the intestine, TREM-1 is highly expressed by macrophages, contributing to inflammatory bowel disease (IBD) pathogenesis. Contrary to current understanding, TREM-2 also promotes inflammation in IBD by fueling dendritic cell functions. This review will focus specifically on recent insights into the role of TREM proteins in IBD development, and discuss opportunities for novel treatment approaches.

Original languageEnglish
Article number293
JournalJournal of Translational Medicine
Volume12
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

Myeloid Cells
Inflammatory Bowel Diseases
Fueling
Macrophages
Coagulation
Osteitis
Bone
Blood
Blood Coagulation
Dendritic Cells
Molecules
Intestines
Communicable Diseases
Homeostasis
Inflammation
Proteins

Keywords

  • Bacterial sensing
  • Inflammation
  • Inflammatory bowel disease
  • Innate immunity
  • Myeloid cells
  • TREM

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis. / Genua, Marco; Rutella, Sergio; Correale, Carmen; Danese, Silvio.

In: Journal of Translational Medicine, Vol. 12, No. 1, 293, 2014.

Research output: Contribution to journalReview article

@article{25fb1ffe9ea046ae99f23b664d861b33,
title = "The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis",
abstract = "The Triggering Receptors Expressed on Myeloid cells (TREM) are a family of cell-surface molecules that control inflammation, bone homeostasis, neurological development and blood coagulation. TREM-1 and TREM-2, the best-characterized receptors so far, play divergent roles in several infectious diseases. In the intestine, TREM-1 is highly expressed by macrophages, contributing to inflammatory bowel disease (IBD) pathogenesis. Contrary to current understanding, TREM-2 also promotes inflammation in IBD by fueling dendritic cell functions. This review will focus specifically on recent insights into the role of TREM proteins in IBD development, and discuss opportunities for novel treatment approaches.",
keywords = "Bacterial sensing, Inflammation, Inflammatory bowel disease, Innate immunity, Myeloid cells, TREM",
author = "Marco Genua and Sergio Rutella and Carmen Correale and Silvio Danese",
year = "2014",
doi = "10.1186/s12967-014-0293-z",
language = "English",
volume = "12",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis

AU - Genua, Marco

AU - Rutella, Sergio

AU - Correale, Carmen

AU - Danese, Silvio

PY - 2014

Y1 - 2014

N2 - The Triggering Receptors Expressed on Myeloid cells (TREM) are a family of cell-surface molecules that control inflammation, bone homeostasis, neurological development and blood coagulation. TREM-1 and TREM-2, the best-characterized receptors so far, play divergent roles in several infectious diseases. In the intestine, TREM-1 is highly expressed by macrophages, contributing to inflammatory bowel disease (IBD) pathogenesis. Contrary to current understanding, TREM-2 also promotes inflammation in IBD by fueling dendritic cell functions. This review will focus specifically on recent insights into the role of TREM proteins in IBD development, and discuss opportunities for novel treatment approaches.

AB - The Triggering Receptors Expressed on Myeloid cells (TREM) are a family of cell-surface molecules that control inflammation, bone homeostasis, neurological development and blood coagulation. TREM-1 and TREM-2, the best-characterized receptors so far, play divergent roles in several infectious diseases. In the intestine, TREM-1 is highly expressed by macrophages, contributing to inflammatory bowel disease (IBD) pathogenesis. Contrary to current understanding, TREM-2 also promotes inflammation in IBD by fueling dendritic cell functions. This review will focus specifically on recent insights into the role of TREM proteins in IBD development, and discuss opportunities for novel treatment approaches.

KW - Bacterial sensing

KW - Inflammation

KW - Inflammatory bowel disease

KW - Innate immunity

KW - Myeloid cells

KW - TREM

UR - http://www.scopus.com/inward/record.url?scp=84988662675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988662675&partnerID=8YFLogxK

U2 - 10.1186/s12967-014-0293-z

DO - 10.1186/s12967-014-0293-z

M3 - Review article

VL - 12

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

IS - 1

M1 - 293

ER -